MARC Record from marc_columbia

LEADER: 05440mam a2200361 a 4500
001 1880390
005 20220609015020.0
008 960926t19961996gw a b 001 0 eng d
020 $a3540613005
035 $a(OCoLC)ocm35639790
035 $9ALW9335CU
035 $a(NNC)1880390
035 $a1880390
040 $aGZM$cGZM$dOrLoB-B
245 00 $aToxoplasma gondii /$cedited by U. Gross.
260 $aBerlin ;$aNew York :$bSpringer,$c[1996], ©1996.
300 $aix, 274 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCurrent topics in microbiology and immunology,$x0070-217X ;$v219
504 $aIncludes bibliographical references and index.
505 00 $tGenetic Basis of Pathogenicity in Toxoplasmosis /$rL. D. Sibley and D. K. Howe --$tDNA Polymorphisms Associated with Murine Virulence of Toxoplasma gondii Identified by RAPD-PCR /$rZ.-G. Guo and A. M. Johnson --$tBiodiversity in Toxoplasma gondii /$rM. L. Darde --$tThe Major Surface Proteins of Toxoplasma gondii: Structures and Functions /$rS. Tomavo --$tToxoplasma gondii Microneme Proteins: Gene Cloning and Possible Function /$rM. N. Fourmaux, N. Garcia-Reguet, O. Mercereau-Puijalon and J. F. Dubremetz --$tRole of Secretory Dense Granule Organelles in the Pathogenesis of Toxoplasmosis /$rM. F. Cesbron-Delauw, L. Lecordier and C. Mercier --$tSerological Recognition of Toxoplasma gondii Cyst Antigens /$rJ. E. Smith, G. McNeil, Y. W. Zhang, S. Dutton, G. Biswas-Hughes and P. Appleford --$tToxoplasma gondii: Kinetics of Stage-Specific Protein Expression During Tachyzoite-Bradyzoite Conversion in Vitro /$rM. Soete and J. F. Dubremetz --
505 80 $tBradyzoite-Specific Genes /$rW. Bohne, S. F. Parmley, S. Yang and U. Gross --$tImmunogenetics in Pathogenesis of and Protection Against Toxoplasmosis /$rR. McLeod, J. Johnson, R. Estes and D. Mack --$tCells and Cytokines in Resistance to Toxoplasma gondii /$rC. A. Hunter, Y. Suzuki, C. S. Subauste and J. S. Remington --$tRole of Macrophage-Derived Cytokines in the Induction and Regulation of Cell-Mediated Immunity to Toxoplasma gondii /$rR. T. Gazzinelli, D. Amichay, T. Sharton-Kersten, E. Grunwald, J. M. Farber and A. Sher --$tRole of Nitric Oxide-Induced Immune Suppression in Toxoplasmosis During Pregnancy and in Infection by a Virulent Strain of Toxoplasma gondii /$rE. Candolfi, O. Villard, M. Thouvenin and T. T. Kien --$tCytokine Production by Human Cells after Toxoplasma gondii Infection /$rH. Pelloux and P. Ambroise-Thomas --$tCharacterization of Human T Cell Clones Specific for Toxoplasma gondii /$rV. Pistoia, P. Facchetti, E. Ghiotto, M. F. Cesbron-Delauw and I. Prigione --
505 80 $tToxoplasma Proteins Recognized by Protective T Lymphocytes /$rH. G. Fischer, G. Reichmann and U. Hadding --$tImmunological Control of Toxoplasma gondii and Appropriate Vaccine Design /$rJ. Alexander, H. Jebbari, H. Bluethmann, A. Satoskar and C. W. Roberts --$tDetection of IgA anti-P30 (SAG1) Antibodies in Acquired and Congenital Toxoplasmosis /$rA. Decoster --$tAIDS-Associated Cerebral Toxoplasmosis: An Update on Diagnosis and Treatment /$rA. Ammassari, R. Murri, A. Cingolani, A. De Luca and A. Antinori --$tCo-infection of Toxoplasma gondii with Other Pathogens: Pathogenicity and Chemotherapy in Animal Models /$rC. Lacroix, M. Bhun-Pascaud, C. Maslo, F. Chau, S. Romand and F. Derouin --$tInfluence of Antimicrobial Agents on Replication and Stage Conversion of Toxoplasma gondii /$rU. Gross and F. Pohl --$tMolecular Genetic Tools for the Identification and Analysis of Drug Targets in Toxoplasma gondii /$rD. S. Roos --
505 80 $tStudies of the Effect of Various Treatments on the Viability of Toxoplasma gondii Tissue Cysts and Oocysts /$rV. Kuticic and T. Wikerhauser.
520 $aFor years, toxoplasmosis has been known as a disease that mostly affects newborns who have acquired Toxoplasma gondii in utero. This parasite has gained increasing interest, because of immunocompromised patients, such as those suffering from AIDS, who present a high risk of reactivation of chronic toxoplasmosis, which can eventually result in fatal cerebral disease.
520 8 $aThe objective of this book is to inform scientists, clinicians, and students of our current knowledge of the interaction between Toxoplasma gondii and its animal or human host.
520 8 $aRecent progress in the development of in vivo and in vitro models and the advent of genetic manipulation has made research of Toxoplasma gondii an evolving area and a model for other protozoan parasites. The chapters of this volume include recent findings on antigens and genes of Toxoplasma gondii and the parasite's interaction with the hosts's immune response.
520 8 $aUsing new technologies, investigations on the developmental differentiation of the parasite have become possible and this knowledge will help us to understand the basis of pathogenesis and persistence of intracellular parasites. Finally, advances in molecular biology and identification of drug targets might lead to new concepts in diagnosis and treatment.
650 0 $aToxoplasma gondii.$0http://id.loc.gov/authorities/subjects/sh88021465
700 1 $aGross, U.$q(Uwe)$0http://id.loc.gov/authorities/names/n96803112
830 0 $aCurrent topics in microbiology and immunology ;$v219.$0http://id.loc.gov/authorities/names/n42036058
852 00 $boff,bio$hQR1$i.C83 v.219